On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...